Business Context and Reporting Period
This Form 8-K is filed by Landec Corporation (not Lifecore Biomedical, Inc., as indicated in the metadata request) on March 25, 2014. The report announces the consolidated financial results for the third quarter of fiscal year 2014. The registrant is incorporated in Delaware with principal executive offices in Menlo Park, California.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are contained within the press release furnished as Exhibit 99.1, which is referenced but not included in the provided text.
Material Changes
The filing does not detail specific material changes versus the prior comparable period. It serves solely as a notification that the third-quarter results have been issued via a press release.
Guidance, Outlook, and Risks
The text does not contain management commentary, forward-looking guidance, specific risk factors, or details on contingencies. The report explicitly states that the information in the press release (Exhibit 99.1) is furnished and shall not be deemed "filed" for purposes of Section 18 of the Exchange Act, nor incorporated by reference unless expressly stated.
Investor Verification Checklist
- Verify the actual financial figures (revenue, net income, EPS) by reviewing Exhibit 99.1 (Press Release dated March 25, 2014), as they are absent from the 8-K body text.
- Confirm the discrepancy between the metadata company name ("LIFECORE BIOMEDICAL, INC.") and the actual registrant ("LANDEC CORPORATION").
- Review the full press release for any forward-looking statements or guidance that may have been issued alongside the results.